Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Commentary | Molecular Biology and Physiology

Lessons Learned from In Vivo Studies of a Viral Noncoding RNA

Rodney P. Kincaid, Christopher S. Sullivan
Rodney P. Kincaid
Department of Molecular Biosciences, Center for Systems and Synthetic Biology, LaMontagne Center for Infectious Disease, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher S. Sullivan
Department of Molecular Biosciences, Center for Systems and Synthetic Biology, LaMontagne Center for Infectious Disease, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00026-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Despite increasing interest in the biology of noncoding RNAs (ncRNAs), few functions have been uncovered for viral ncRNAs in vivo. In their recent article in mSphere, Feldman and colleagues [E. R. Feldman et al., mSphere 1(2):e00105-15, 2016, doi:10.1128/mSphere.00105-15 ] demonstrate a highly specific activity of a gammaherpesviral ncRNA in viral dissemination and establishment of latent infection. Their work highlights several interesting features that should be informative to future studies of viral ncRNA.

The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.

TEXT

The field of non-protein-coding regulatory RNA, or noncoding RNA (ncRNA), has gained much momentum in the last decade. ncRNA has been implicated in important aspects of all domains of life. In eukaryotes, ncRNAs derive from a collection of numerous different classes of RNAs with lengths ranging from 20 nucleotides to kilobases. Many ncRNAs have been implicated in transcriptional and posttranscriptional control of gene expression, with the microRNA (miRNA) class of ncRNAs being among the best characterized. Although often overlooked, some of the first well-characterized ncRNAs are of viral origin (1, 2). These include the adenoviral virus-associated RNAs (VA RNAs) and the herpesviral HSUR and EBER RNAs, each being first described over 25 years ago (3–5). Despite being among the best characterized, important questions remain even about these viral ncRNAs, including a full detailed mechanistic understanding of their molecular activities as well as their relevant functions in vivo. In fact, the functions of the majority of viral ncRNAs are completely unknown, and very few have been studied in the context of infection in vivo.

Gammaherpesviruses replicate and persist predominantly in lymphoid cells and are etiologic agents of several types of cancers (6). Typically, these cancers are associated with an immunocompromised host. In humans, the two known gammaherpesviruses are Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV), and both are associated with lymphoid and solid tumors (7). Most if not all herpesviruses encode ncRNAs. EBV and KSHV both encode miRNAs, small RNAs that dock to mRNAs and direct decreased steady-state mRNA levels and inhibition of translation. In addition, EBV encodes EBERs, RNA polymerase III (Pol III)-transcribed ncRNAs that are the most abundant viral transcripts in infected cells (up to 107 copies/cell) (4). Because infection with both EBV and KSHV is species specific, there remains a limited understanding of their life cycles in vivo. In contrast, studies of the murine gammaherpesvirus 68 (MHV68) can readily take advantage of well-established laboratory in vivo mouse experimental systems. Like KSHV and EBV, MHV68 infects B cells, is associated with pathogenesis in immunocompromised hosts, and encodes abundant ncRNAs during lytic and latent infection.

MHV68 encodes a unique class of ncRNAs that are now known as tRNA-microRNA-encoded RNAs (TMERs). The TMERs were first reported as a cluster of eight nonaminoacylated viral transfer RNAs (vtRNAs) that were expressed in both latently and lytically infected cells (8). However, in 2005, Pfeffer et al. identified miRNAs encoded immediately following the MHV68 vtRNAs (9). It was later confirmed that the vtRNAs and viral miRNAs are cotranscribed by RNA Pol III (10, 11). The primary TMER transcripts are processed by the host enzyme tRNase Z, which results in the separation of the vtRNAs from the pre-miRNA structures (11). This unusual arrangement allows the TMER genes to produce two different classes of ncRNAs. Previous studies from some of the same labs involved in this current work of Feldman et al. (12) mostly focused on TMER mutant viruses defective for expression of numerous viral ncRNAs (13, 14). These studies showed that TMERs are dispensable for infection in cultured cells but can have activities in vivo related to both pathogenesis and latency. These results suggest that the MHV68 TMERs are multifunctional ncRNAs and that further studies of individual TMERs are required to decode their full repertoire of functions.

In their most recent report, Feldman and colleagues uncover an interesting phenotype for a deletion mutant virus that abrogates a single TMER, TMER4 (12). TMER4 is shown to be important for establishing latent infection. While a worthy observation in itself, it is particularly notable that the authors demonstrated that this defect can be bypassed by utilizing a different, less natural route of inoculation. While mice intranasally (i.n.) inoculated with the TMER4 mutant virus had a substantially reduced number of latently infected B cells, mice that were inoculated intraperitoneally (i.p.) directly into the abdominal cavity showed no defect. The authors then demonstrated that TMER4 is not required for acute lytic infection. Furthermore, there were no defects in infectious virus levels or the fraction of latently infected cells in the lung-draining lymph nodes, the tissue that is the most likely portal for viral dissemination from the lung to circulating leukocytes. In contrast, at a time postinfection when wild-type virus is detectable in white blood cells but not yet in peripheral sites, such as the spleen, the TMER4 mutant virus showed a strong defect in viral genome copy number in leukocytes. Based on results of a painstaking series of experiments and a process of elimination, the authors compellingly argue that TMER4 functions to promote virus dissemination. Thus, from the lung-draining lymph nodes, viruses lacking TMER4 cannot effectively gain access to the vasculature leukocytes and subsequent peripheral sites of infection (Fig. 1).

FIG 1 
  • Open in new tab
  • Download powerpoint
FIG 1 

TMER4, a murine gammaherpesviral ncRNA, likely functions to promote dissemination from lung-draining lymph nodes to vasculature leukocytes and subsequent peripheral sites of infection. The study of Feldman et al. (12) identified a new activity for a viral ncRNA. Yellow question marks illustrate some interesting molecular and physiological questions raised by their study. The tRNA-like (vtRNA) and pre-miRNA portions of the TMER ncRNA are indicated.

In addition to the observation that the route of inoculation can profoundly affect phenotype, this work uncovered several other findings that are likely instructive for other viral ncRNAs. First, TMERs are “polyfunctional.” Like adenovirus VA RNAs that have functions ascribed to the longer ncRNAs as well as their miRNA derivatives (15), the longer TMERs have functions that are separate from their miRNA derivatives. Here, Feldman and colleagues demonstrate that the miRNA derivatives of the TMER4 are dispensable for its activities in dissemination and establishment of latency. Second, adding an interesting twist, it has been previously shown that mutation of all MHV68 miRNAs results in only a mild defect in establishing latency in vivo (13). This argues that one or more TMERs may have deleterious activities that are countered by TMER4.

Feldman and colleagues have presented a methodical study that uncovers one of the few in vivo activities known for a viral ncRNA. However, many unanswered questions remain. Is it possible that lung-draining lymph node-independent routes exist to allow peripheral infection? Does TMER4 function only to regulate the deleterious effects of another TMER(s)? What is the relevant function of TMER4 miRNAs? And, perhaps most interestingly, what is the molecular activity of TMER4 that accounts for its role in dissemination? The lessons learned from this study are humbling and should be of value to the design of future studies of viral ncRNA. Not only would the phenotype of the TMER4 mutant virus have been missed in cultured cells, but it would have been missed in vivo if an alternative route of inoculation or a less surgical mutant virus design strategy had been used. Such work illustrates the power of fully infectious murine viral experimental systems. It remains to be seen if human-pathogenic viruses utilize ncRNAs to promote similar dissemination-dependent persistent infections.

ACKNOWLEDGMENTS

We gratefully acknowledge Lisa Williams of Drawings by Lisa for her original design and hand-drawn and digital art contributions to Fig. 1. We also thank Jason Upton for helpful comments.

Work in the Sullivan lab is supported by a Burroughs Wellcome Investigators in Pathogenesis Award, grant RP110098 from the Cancer Prevention and Research Institute of Texas, a grant from the Alpha-1 Foundation, and the University of Texas at Austin Institute for Cellular and Molecular Biology.

FOOTNOTES

  • For the article discussed, see http://doi.org/10.1128/mSphere.00105-15.

  • Copyright © 2016 Kincaid and Sullivan.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license .

REFERENCES

  1. 1.↵
    1. Sullivan C,
    2. Cullen B
    . 2009. Noncoding regulatory RNAs of the DNA tumor viruses, p 645–682. In Damania B, Pipas J (ed), DNA tumor viruses. Springer-Verlag, New York, NY.
  2. 2.↵
    1. Sullivan CS
    . 2008. New roles for large and small viral RNAs in evading host defences. Nat Rev Genet9:503–507. doi:10.1038/nrg2349.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Reich PR,
    2. Forget BG,
    3. Weissman SM,
    4. Rose JA
    . 1966. RNA of low molecular weight in KB cells infected with adenovirus type 2. J Mol Biol17:428–439.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lerner MR,
    2. Andrews NC,
    3. Miller G,
    4. Steitz JA
    . 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A78:805–809. doi:10.1073/pnas.78.2.805.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Lee SI,
    2. Murthy SC,
    3. Trimble JJ,
    4. Desrosiers RC,
    5. Steitz JA
    . 1988. Four novel U RNAs are encoded by a herpesvirus. Cell54:599–607. doi:10.1016/S0092-8674(88)80004-7.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Blossom D
    . 2007. EBV and KSHV-related herpesviruses in non-human primates, p 1093–1116. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
  7. 7.↵
    1. Pinzone MR,
    2. Berretta M,
    3. Cacopardo B,
    4. Nunnari G
    . 2015. Epstein-Barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection. Semin Oncol42:258–271. doi:10.1053/j.seminoncol.2014.12.026.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Bowden RJ,
    2. Simas JP,
    3. Davis AJ,
    4. Efstathiou S
    . 1997. Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency. J Gen Virol78:1675–1687. doi:10.1099/0022-1317-78-7-1675.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Pfeffer S,
    2. Sewer A,
    3. Lagos-Quintana M,
    4. Sheridan R,
    5. Sander C,
    6. Grässer FA,
    7. van Dyk LF,
    8. Ho CK,
    9. Shuman S,
    10. Chien M,
    11. Russo JJ,
    12. Ju J,
    13. Randall G,
    14. Lindenbach BD,
    15. Rice CM,
    16. Simon V,
    17. Ho DD,
    18. Zavolan M,
    19. Tuschl T
    . 2005. Identification of microRNAs of the herpesvirus family. Nat Methods2:269–276. doi:10.1038/nmeth746.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Diebel KW,
    2. Smith AL,
    3. van Dyk LF
    . 2010. Mature and functional viral miRNAs transcribed from novel RNA polymerase III promoters. RNA16:170–185. doi:10.1261/rna.1873910.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Bogerd HP,
    2. Karnowski HW,
    3. Cai X,
    4. Shin J,
    5. Pohlers M,
    6. Cullen BR
    . 2010. A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral microRNAs. Mol Cell37:135–142. doi:10.1016/j.molcel.2009.12.016.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Feldman ER,
    2. Kara M,
    3. Oko LM,
    4. Grau KR,
    5. Krueger BJ,
    6. Zang J,
    7. Feng P,
    8. van Dyk LF,
    9. Renne R,
    10. Tibbetts SA
    . 2016. A gammaherpesvirus noncoding RNA is essential for hematogenous dissemination and establishment of peripheral latency. mSphere1(2):e00105-15. doi:10.1128/mSphere.00105-15.
    OpenUrlCrossRef
  13. 13.↵
    1. Feldman ER,
    2. Kara M,
    3. Coleman CB,
    4. Grau KR,
    5. Oko LM,
    6. Krueger BJ,
    7. Renne R,
    8. van Dyk LF,
    9. Tibbetts SA
    . 2014. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. mBio5:e00981-14. doi:10.1128/mBio.00981-14.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Diebel KW,
    2. Oko LM,
    3. Medina EM,
    4. Niemeyer BF,
    5. Warren CJ,
    6. Claypool DJ,
    7. Tibbetts SA,
    8. Cool CD,
    9. Clambey ET,
    10. van Dyk LF
    . 2015. Gammaherpesvirus small noncoding RNAs are bifunctional elements that regulate infection and contribute to virulence in vivo. mBio6:e01670-14. doi:10.1128/mBio.01670-14.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Punga T,
    2. Kamel W,
    3. Akusjärvi G
    . 2013. Old and new functions for the adenovirus virus-associated RNAs. Future Virol8:343–356. doi:10.2217/fvl.13.19.
    OpenUrlCrossRef
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Lessons Learned from In Vivo Studies of a Viral Noncoding RNA
Rodney P. Kincaid, Christopher S. Sullivan
mSphere Mar 2016, 1 (2) e00026-16; DOI: 10.1128/mSphere.00026-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Lessons Learned from In Vivo Studies of a Viral Noncoding RNA
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Lessons Learned from In Vivo Studies of a Viral Noncoding RNA
Rodney P. Kincaid, Christopher S. Sullivan
mSphere Mar 2016, 1 (2) e00026-16; DOI: 10.1128/mSphere.00026-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Epstein-Barr virus
Kaposi's sarcoma-associated herpesvirus
gammaherpesvirus
latency
microRNA
noncoding RNA
viral dissemination

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042